Researchers at University of Göttingen, Germany, have identified nerve excitability of motor nerve cells...
Up To Date
Latest News
AstraZeneca plc has sold US rights to its off-patent blockbuster drug Synagis (palivizumab) and a 50% share on...
Swiss Amal Therapeutics S.A. (Geneva) has raised €21.2m in a series B follow-up financing.
Antimicrobial resistance (AMR) has increased by 32% since 2007 in Europe, according to a brand new report.
A new method developed by Swiss, Danish and British researchers allows to detect hard-to-trace tumour-derived...
One week after Austrian vaccine and cancer immunotherapy specialist Bioscience announced the terms of its...